Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeoProtein is a biotechnology company specializing in the de novo design of functional proteins using a proprietary computational platform. Founded as a spin-out from Rutgers University, the company leverages geometric principles to engineer novel protein structures with high stability and specific biological activities. GeoProtein's technology is being applied to develop next-generation therapeutics in areas such as regenerative medicine, oncology, and infectious diseases. By creating proteins that do not exist in nature, the company aims to overcome the limitations of traditional protein engineering and address significant unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GeoProtein.